parkin RBR E3 ubiquitin protein ligase
Last updated 17 Jul 2023
Meets Patient’s editorial guidelines
- DownloadDownload
- Share
- Language
- Discussion
- Ask Patient
- Audio Version
- Add to preferred sources on Google
The PRKN gene, one of the largest human genes, provides instructions for making a protein called parkin. Parkin plays a role in the cell machinery that breaks down (degrades) unneeded proteins by tagging damaged and excess proteins with molecules called ubiquitin. Ubiquitin serves as a signal to move unneeded proteins into specialized cell structures known as proteasomes, where the proteins are degraded. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins. This system also regulates the availability of proteins that are involved in several critical cell activities, such as the timing of cell division and growth. Because of its activity in the ubiquitin-proteasome system, parkin belongs to a group of proteins called E3 ubiquitin ligases.
Video picks for GenesVideo library
Normal function
The PRKN gene, one of the largest human genes, provides instructions for making a protein called parkin. Parkin plays a role in the cell machinery that breaks down (degrades) unneeded proteins by tagging damaged and excess proteins with molecules called ubiquitin. Ubiquitin serves as a signal to move unneeded proteins into specialized cell structures known as proteasomes, where the proteins are degraded. The ubiquitin-proteasome system acts as the cell's quality control system by disposing of damaged, misshapen, and excess proteins. This system also regulates the availability of proteins that are involved in several critical cell activities, such as the timing of cell division and growth. Because of its activity in the ubiquitin-proteasome system, parkin belongs to a group of proteins called E3 ubiquitin ligases.
Parkin appears to be involved in the maintenance of mitochondria, the energy-producing centers in cells. However, little is known about its role in mitochondrial function. Research suggests that parkin may help trigger the destruction of mitochondria that are not working properly.
Studies of the structure and activity of parkin have led researchers to propose several additional activities for this protein. Parkin may act as a tumour suppressor protein, which means it prevents cells from growing and dividing too rapidly or in an uncontrolled way. Parkin may also regulate the supply and release of sacs called synaptic vesicles from nerve cells. Synaptic vesicles contain chemical messengers that transmit signals from one nerve cell to another.
Conditions referring to this gene or chromosome
Other names
AR-JP
PARK2
parkin
Parkinson disease (autosomal recessive, juvenile) 2, parkin
parkinson protein 2, E3 ubiquitin protein ligase (parkin)
PDJ
PRKN2_HUMAN
ubiquitin E3 ligase
Patient picks for Genes

Brain and nerves
Parkinson's disease
The main symptoms of Parkinson's disease are usually stiffness, shaking (tremor), and slowness of movement. People with Parkinson's may also develop other symptoms (listed below). Symptoms typically become gradually worse over time. Treatment often provides good relief of symptoms for several years.
by Dr Colin Tidy, MRCGP

Brain and nerves
Prostate cancer drug could slow down Parkinson's disease
A study has found that a drug used to treat an enlarged prostate could also slow the progression of Parkinson's disease.
by Milly Evans

Brain and nerves
Could it be Parkinson's disease?
Parkinson's disease affects the brain cells and nerves that help you move your muscles in a co-ordinated way. It mostly affects people over 50 - about 1 in 200 people in their 60s and 1 in 50 over-80s. There are exceptions - Michael J. Fox developed the condition young - and in younger people, it's more likely to run in families.
by Dr Sarah Jarvis

Brain and nerves
What worsens Parkinson's disease?
Parkinson's disease is a progressive loss of certain nerve cells (dopaminergic cells) within specific areas of the brain (the substantia nigra). It is not known exactly what causes Parkinson's disease but it seems to be a combination of genetic and environmental factors.
by Dr Colin Tidy, MRCGP

Brain and nerves
What is the link between Parkinson's disease and dementia?
Parkinson's and dementia are separate conditions, with many people developing one without the other. This said, people with Parkinson's have a higher risk of dementia, particularly during old age. The two main types of dementia that people with Parkinson's can develop are 'Parkinson's dementia' and 'dementia with Lewy bodies'.
by Amberley Davis

Healthy living
Natural protein verses protein powder: which is better for strength training?
Consuming enough protein is essential for building strong muscles. Protein powder shakes are not a complete replacement for natural protein sources found in your food. However, you may consider supplementing your diet and strength-training regime with protein shakes. Before you decide if this is right for you, there are several benefits and considerations to take into account.
by Amberley Davis
Related patient information and medicines

Patient information leaflet
Can I take Lactulose and Ropinirole together?
It is generally safe to take these two medicines together. Why this happens Lactulose is a laxative that stays in the bowel and is not absorbed into the bloodstream. Ropinirole is absorbed into the blood to treat Parkinson's disease or Restless Legs Syndrome. Because they work in different parts of the body and are processed through different.

Patient information leaflet
Mediterranean diet
High blood pressure High blood pressure. Obesity How to lower your BMI and lose weight healthily. Some cancers. Parkinson's disease Parkinson's disease. Alzheimer's disease Alzheimer's disease. It can also be useful for people wishing to lose weight as it is rich in fruit and vegetables and lower in sugars and saturated fats than a typical Western.

Patient information leaflet
Parkinson's disease
The main symptoms of Parkinson's disease are usually stiffness, shaking (tremor), and slowness of movement. People with Parkinson's may also develop other symptoms (listed below). Symptoms typically become gradually worse... What is Parkinson's disease. Parkinson's disease is a progressive neurological degeneration of certain cells (called.

Patient information leaflet
Can I take Amitriptyline and Esomeprazole together?
Taking esomeprazole alongside amitriptyline may increase the levels of amitriptyline in your bloodstream. This could make you ... Why this happens Amitriptyline is broken down in the liver by specific proteins (enzymes). Using other medicines Taking multiple medicines. Our Medicines Interaction Checker helps you check whether your prescriptions,.

Patient information leaflet
Contact lenses
Care of contact lenses is aimed at preventing them from becoming contaminated with chemicals or debris, or with bugs (pathogens) that can damage your eyes. In particular a bug called acanthamoeba can cause serious eye infection. Care of your eyes involves washing your hands, thoroughly and with soap (avoiding moisturising soaps, which are not good.

Patient information leaflet
Bottle-feeding your baby
What is cow's milk allergy. Cow's milk allergy (or cow's milk protein allergy, CMPA) is an allergy to one or more types of the main proteins in milk, casein and whey. It affects around 1 in 15 babies under a year old, although it is less common in exclusively breast-fed babies (only around 1 in 200), it is more common in babies who have, or whose.
Further reading and references
- parkin RBR E3 ubiquitin protein ligase; MedlinePlus, National Library of Medicine.
- Abou-Sleiman PM, Muqit MM, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat Rev Neurosci. 2006 Mar;7(3):207-19. doi: 10.1038/nrn1868.
- Dawson TM, Dawson VL. The role of parkin in familial and sporadic Parkinson's disease. Mov Disord. 2010;25 Suppl 1(0 1):S32-9. doi: 10.1002/mds.22798.
- Denison SR, Callahan G, Becker NA, Phillips LA, Smith DI. Characterization of FRA6E and its potential role in autosomal recessive juvenile parkinsonism and ovarian cancer. Genes Chromosomes Cancer. 2003 Sep;38(1):40-52. doi: 10.1002/gcc.10236.
- Denison SR, Wang F, Becker NA, Schule B, Kock N, Phillips LA, Klein C, Smith DI. Alterations in the common fragile site gene Parkin in ovarian and other cancers. Oncogene. 2003 Nov 13;22(51):8370-8. doi: 10.1038/sj.onc.1207072.
- Kay DM, Stevens CF, Hamza TH, Montimurro JS, Zabetian CP, Factor SA, Samii A, Griffith A, Roberts JW, Molho ES, Higgins DS, Gancher S, Moses L, Zareparsi S, Poorkaj P, Bird T, Nutt J, Schellenberg GD, Payami H. A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2. Neurology. 2010 Sep 28;75(13):1189-94. doi: 10.1212/WNL.0b013e3181f4d832.
- Mira MT, Alcais A, Nguyen VT, Moraes MO, Di Flumeri C, Vu HT, Mai CP, Nguyen TH, Nguyen NB, Pham XK, Sarno EN, Alter A, Montpetit A, Moraes ME, Moraes JR, Dore C, Gallant CJ, Lepage P, Verner A, Van De Vosse E, Hudson TJ, Abel L, Schurr E. Susceptibility to leprosy is associated with PARK2 and PACRG. Nature. 2004 Feb 12;427(6975):636-40. doi: 10.1038/nature02326. Epub 2004 Jan 25.
- Narendra DP, Youle RJ. Targeting mitochondrial dysfunction: role for PINK1 and Parkin in mitochondrial quality control. Antioxid Redox Signal. 2011 May 15;14(10):1929-38. doi: 10.1089/ars.2010.3799. Epub 2011 Mar 3.
- Picchio MC, Martin ES, Cesari R, Calin GA, Yendamuri S, Kuroki T, Pentimalli F, Sarti M, Yoder K, Kaiser LR, Fishel R, Croce CM. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004 Apr 15;10(8):2720-4. doi: 10.1158/1078-0432.ccr-03-0086.
- Pramstaller PP, Schlossmacher MG, Jacques TS, Scaravilli F, Eskelson C, Pepivani I, Hedrich K, Adel S, Gonzales-McNeal M, Hilker R, Kramer PL, Klein C. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol. 2005 Sep;58(3):411-22. doi: 10.1002/ana.20587.
- Schurr E, Alcais A, de Leseleuc L, Abel L. Genetic predisposition to leprosy: A major gene reveals novel pathways of immunity to Mycobacterium leprae. Semin Immunol. 2006 Dec;18(6):404-10. doi: 10.1016/j.smim.2006.07.005. Epub 2006 Sep 14.
- Shimura H, Hattori N, Kubo Si, Mizuno Y, Asakawa S, Minoshima S, Shimizu N, Iwai K, Chiba T, Tanaka K, Suzuki T. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet. 2000 Jul;25(3):302-5. doi: 10.1038/77060.
- Veeriah S, Taylor BS, Meng S, Fang F, Yilmaz E, Vivanco I, Janakiraman M, Schultz N, Hanrahan AJ, Pao W, Ladanyi M, Sander C, Heguy A, Holland EC, Paty PB, Mischel PS, Liau L, Cloughesy TF, Mellinghoff IK, Solit DB, Chan TA. Somatic mutations of the Parkinson's disease-associated gene PARK2 in glioblastoma and other human malignancies. Nat Genet. 2010 Jan;42(1):77-82. doi: 10.1038/ng.491. Epub 2009 Nov 29.
- von Coelln R, Dawson VL, Dawson TM. Parkin-associated Parkinson's disease. Cell Tissue Res. 2004 Oct;318(1):175-84. doi: 10.1007/s00441-004-0924-4. Epub 2004 Jul 30.
Share your thoughts or experiences with others in our patient communities.
Sign up to the Patient newsletter
Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.
By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.

